The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment: Role of the renin angiotensin system inhibition

BMC Geriatrics

Volumn 9, Issue 1, 2009, Pages

  Hajjar, Ihab ^a,b,c   Hart, Meaghan ^b   Milberg, William ^a,d   Novak, Vera ^a,c   Lipsitz, Lewis ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Hebrew Senior Life   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d General Internal Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; CANDESARTAN; CARBON DIOXIDE; HYDROCHLOROTHIAZIDE; LISINOPRIL; METOPROLOL; NIFEDIPINE; RENIN; ANTIHYPERTENSIVE AGENT;

AGED; AGING; ARTICLE; BLOOD PRESSURE REGULATION; BRAIN BLOOD FLOW; CELL FUNCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFECT; DRUG MECHANISM; END TIDAL CARBON DIOXIDE TENSION; ENDOTHELIUM CELL; EXPERIMENTAL DESIGN; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MEMORY; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT DURATION; UNITED STATES; CARDIOVASCULAR DISEASE; CLINICAL PROTOCOL; COGNITIVE DEFECT; COMPARATIVE STUDY; MIDDLE AGED; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; TIME; VASCULAR ENDOTHELIUM;

AGED; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; CLINICAL PROTOCOLS; COGNITION DISORDERS; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION; MIDDLE AGED; RENIN-ANGIOTENSIN SYSTEM; TIME FACTORS;

EID: 72949089777     PISSN: None     EISSN: 14712318     Source Type: Journal    
DOI: 10.1186/1471-2318-9-48     Document Type: Article

References (98)

1. Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. L Kilander H Nyman M Boberg L Hansson H Lithell, Hypertension 1998 31 780 786 9495261
2. Blood pressure and cognitive functioning among independent elderly. E Paran O Anson H Reuveni, Am J Hypertens 2003 16 818 826 10.1016/S0895-7061(03) 01005-7 14553960
3. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. LJ Launer K Masaki H Petrovitch D Foley RJ Havlik, Jama 1995 274 1846 1851 10.1001/jama.274.23.1846 7500533
4. Cardiovascular risk factors and cognitive decline in middle-aged adults. D Knopman LL Boland T Mosley G Howard D Liao M Szklo P McGovern AR Folsom, Neurology 2001 56 42 48 11148234
5. Hypertension and changes of cognitive function in 81-year-old men: a 13-year follow-up of the population study "Men born in 1914", Sweden. F Reinprecht S Elmstahl L Janzon L Andre-Petersson, J Hypertens 2003 21 57 66 10.1097/00004872-200301000-00014 12544436 (Pubitemid 36143509)
6. Hypertension and the rate of cognitive decline in patients with dementia of the Alzheimer type. KM Bellew JG Pigeon PE Stang W Fleischman RM Gardner WW Baker, Alzheimer Dis Assoc Disord 2004 18 208 213 15592132
7. Hypertension and cognitive performance in African Americans with Alzheimer disease. FC Goldstein AV Ashley LJ Freedman L Penix JJ Lah J Hanfelt AI Levey, Neurology 2005 64 899 901 10.1212/01.WNL.0000164712.24389.BB 15753433
8. Selective impairment of frontal-executive cognitive function in african americans with cardiovascular risk factors. KG Pugh DK Kiely WP Milberg LA Lipsitz, J Am Geriatr Soc 2003 51 1439 1444 10.1046/j.1532-5415.2003.51463.x 14511165
9. Effects of hypertension on attention, memory, and executive function in older adults. BK Saxby F Harrington IG McKeith K Wesnes GA Ford, Health Psychol 2003 22 587 591 10.1037/0278-6133.22.6.587 14640855
10. Effect of blood pressure on cognitive functions in elderly persons. HK Kuo F Sorond I Iloputaife M Gagnon W Milberg LA Lipsitz, J Gerontol A Biol Sci Med Sci 2004 59 1191 1194 15602074
11. Executive Control Function: A Review of Its Promise and Challenges for Clinical Research. A Report From the Committee on Research of the American Neuropsychiatric Association. DR Royall EC Lauterbach JL Cummings A Reeve TA Rummans DI Kaufer WC LaFrance Jr CE Coffey, J Neuropsychiatry Clin Neurosci 2002 14 377 405 12426407
12. Executive control and the comprehension of medical information by elderly retirees. DR Royall J Cordes M Polk, Exp Aging Res 1997 23 301 313 10.1080/03610739708254033 9352289
13. Prediction of functional status from neuropsychological tests in community-dwelling elderly individuals. DA Cahn-Weiner PF Malloy PA Boyle M Marran S Salloway, Clin Neuropsychol 2000 14 187 195 10916193
14. Declining executive control in normal aging predicts change in functional status: the Freedom House Study. DR Royall R Palmer LK Chiodo MJ Polk, J Am Geriatr Soc 2004 52 346 352 10.1111/j.1532-5415.2004.52104.x 14962147
15. Prevalence of disorders of executive cognitive functioning among the elderly: findings from the San Luis Valley Health and Aging Study. J Grigsby K Kaye SM Shetterly J Baxter NE Morgenstern RF Hamman, Neuroepidemiology 2002 21 213 220 10.1159/000065638 12207148
16. Prevalence and patterns of executive impairment in community dwelling Mexican Americans: results from the Hispanic EPESE Study. DR Royall DV Espino MJ Polk RF Palmer KS Markides, Int J Geriatr Psychiatry 2004 19 926 934 10.1002/gps.1185 15449370
17. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. A Ruitenberg T den Heijer SL Bakker JC van Swieten PJ Koudstaal A Hofman MM Breteler, Ann Neurol 2005 57 789 794 10.1002/ana.20493 15929050
18. Volume cerebral blood flow reduction in pre-clinical stage of Alzheimer disease: evidence from an ultrasonographic study. N Maalikjy Akkawi B Borroni C Agosti M Magoni M Broli A Pezzini A Padovani, J Neurol 2005 252 559 563 10.1007/s00415-005-0689-z 15726249
19. Cerebrovascular reactivity and cognitive decline in patients with Alzheimer disease. M Silvestrini P Pasqualetti R Baruffaldi M Bartolini Y Handouk M Matteis F Moffa L Provinciali F Vernieri, Stroke 2006 37 1010 1015 10.1161/01.STR.0000206439.62025.97 16497984
20. Correlates of middle cerebral artery blood velocity in the elderly. SF Ameriso A Paganini-Hill HJ Meiselman M Fisher, Stroke 1990 21 1579 1583 2237952
21. Sex differences in human brain morphometry and metabolism: an in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging. DG Murphy C DeCarli AR McIntosh E Daly MJ Mentis P Pietrini J Szczepanik MB Schapiro CL Grady B Horwitz SI Rapoport, Arch Gen Psychiatry 1996 53 585 594 8660125
22. Transcranial color Doppler sonography of basal cerebral arteries in 182 healthy subjects: age and sex variability and normal reference values for blood flow parameters. J Krejza Z Mariak J Walecki P Szydlik J Lewko A Ustymowicz, AJR Am J Roentgenol 1999 172 213 218 9888770
23. Influence of erythrocyte aggregability and plasma fibrinogen concentration on CBF with aging. R Cavestri L Radice F Ferrarini M Longhini E Longhini, Acta Neurol Scand 1992 85 292 298 10.1111/j.1600-0447.1992.tb01472.x 1585800
24. Angiotensin II attenuates functional hyperemia in the mouse somatosensory cortex. K Kazama G Wang K Frys J Anrather C Iadecola, Am J Physiol Heart Circ Physiol 2003 285 1890 1899 12907423
25. Cerebral pressure-flow relations in hypertensive elderly humans: transfer gain in different frequency domains. JM Serrador FA Sorond M Vyas M Gagnon ID Iloputaife LA Lipsitz, J Appl Physiol 2005 98 151 159 10.1152/japplphysiol. 00471.2004 15361517
26. Angiotensin II AT1 receptor blockade reverses pathological hypertrophy and inflammation in brain microvessels of spontaneously hypertensive rats. H Ando J Zhou M Macova H Imboden JM Saavedra, Stroke 2004 35 1726 1731 10.1161/01.STR.0000129788.26346.18 15143297 (Pubitemid 38823655)
27. The role of angiotensin II in cognition and behaviour. PR Gard, Eur J Pharmacol 2002 438 1 14 10.1016/S0014-2999(02)01283-9 11906704
28. Angiotensin and cerebral blood flow. JM Saavedra Y Nishimura, Cell Mol Neurobiol 1999 19 553 573 10.1023/A:1006995016403 10384255
29. Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals. K Kazama J Anrather P Zhou H Girouard K Frys TA Milner C Iadecola, Circ Res 2004 95 1019 1026 10.1161/01.RES.0000148637.85595.c5 15499027
30. Angiotensin degradation products mediate endothelium-dependent dilation of rabbit brain arterioles. RL Haberl PJ Decker KM Einhaupl, Circ Res 1991 68 1621 1627 2036715
31. Angiotensin II-induced hypertension is associated with a selective inhibition of endothelium-derived hyperpolarizing factor-mediated responses in the rat mesenteric artery. S Dal-Ros C Bronner C Schott MO Kane M Chataigneau VB Schini-Kerth T Chataigneau, J Pharmacol Exp Ther 2009 328 478 486 10.1124/jpet.108.145326 18984652
32. Angiotensin, bradykinin and the endothelium. C Dimitropoulou A Chatterjee L McCloud G Yetik-Anacak JD Catravas, Handb Exp Pharmacol 2006 255 294 full-text 16999222
33. Impaired peripheral endothelial microvascular responsiveness in Alzheimer's disease. Z Khalil D LoGiudice B Khodr P Maruff C Masters, J Alzheimers Dis 2007 11 25 32 17361032
34. Aging and hypertension: what about the endothelium? L Ghiadoni A Virdis, J Hypertens 2006 24 1243 1244 10.1097/01.hjh.0000234100.93120.c5 16794469
35. The ageing endothelium, cardiovascular risk and disease in man. D Versari E Daghini A Virdis L Ghiadoni S Taddei, Exp Physiol 2009 94 317 321 10.1113/expphysiol.2008.043356 18805864
36. Endothelium, aging, and hypertension. S Taddei A Virdis L Ghiadoni D Versari A Salvetti, Curr Hypertens Rep 2006 8 84 89 10.1007/s11906-006-0045-4 16600164
37. Aging and the endothelium. P d'Alessio, Exp Gerontol 2004 39 165 171 10.1016/j.exger.2003.10.025 15038389
38. Vascular smooth muscle function is associated with initiation and processing speed in patients with atherosclerotic vascular disease. DJ Moser IN Miller KF Hoth M Correia S Arndt WG Haynes, J Int Neuropsychol Soc 2008 14 535 541 10.1017/S1355617708080697 18577282
39. Early morning impairment in cerebral autoregulation and cerebrovascular CO2 reactivity in healthy humans: relation to endothelial function. PN Ainslie C Murrell K Peebles M Swart MA Skinner MJ Williams RD Taylor, Exp Physiol 2007 92 769 777 10.1113/expphysiol.2006.036814 17384117
40. Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo. D Ai Y Fu D Guo H Tanaka N Wang C Tang BD Hammock JY Shyy Y Zhu, Proc Natl Acad Sci USA 2007 104 9018 9023 10.1073/pnas.0703229104 17495027
41. Preservation of cognitive function with antihypertensive medications: a longitudinal analysis of a community-based sample of African Americans. MD Murray KA Lane S Gao RM Evans FW Unverzagt KS Hall H Hendrie, Arch Intern Med 2002 162 2090 2096 10.1001/archinte.162.18.2090 12374517
42. Hypertension and cognitive function: pathophysiologic effects of hypertension on the brain. TA Manolio J Olson WT Longstreth, Curr Hypertens Rep 2003 5 255 261 10.1007/s11906-003-0029-6 12724059
43. Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure. E Roig F Perez-Villa M Morales W Jimenez J Orus M Heras G Sanz, Eur Heart J 2000 21 53 57 10.1053/euhj.1999.1740 10610744
44. Angiotensin-converting enzyme-independent contraction to angiotensin I in human resistance arteries. N Padmanabhan AG Jardine JC McGrath JM Connell, Circulation 1999 99 2914 2920 10359736
45. Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients. MA Tedesco G Ratti S Mennella G Manzo M Grieco AC Rainone D Iarussi A Iacono, Am J Hypertens 1999 12 1130 1134 10.1016/S0895-7061(99)00156-9 10604491
46. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. C Tzourio C Anderson N Chapman M Woodward B Neal S MacMahon J Chalmers, Arch Intern Med 2003 163 1069 1075 10.1001/archinte.163.9.1069 12742805 (Pubitemid 36548935)
47. Alzheimer disease. JL Cummings G Cole, Jama 2002 287 2335 2338 10.1001/jama.287.18.2335 11988038
48. Limitation of the Mini-Mental State Examination for the detection of amnesia. RH Benedict J Brandt, J Geriatr Psychiatry Neurol 1992 5 233 237 1418369
49. [Ramipril in elderly patients with mild and moderate hypertension. Clinical efficacy, effect on cerebral blood flow and intellectual functioning]. GV Pogosova NI Zhidko NS Ivanishina OA Gudkova GN Avakian, Kardiologiia 2003 43 42 47 12891310
50. Captopril and enalapril improve cognition and depressed mood in hypertensive patients. JJ Braszko W Karwowska-Polecka D Halicka PR Gard, J Basic Clin Physiol Pharmacol 2003 14 323 343 15198305
51. Use of angiotensin-converting enzyme inhibitors and variations in cognitive performance among patients with heart failure. G Zuccala G Onder E Marzetti MR Monaco M Cesari A Cocchi P Carbonin R Bernabei, Eur Heart J 2005 26 226 233 10.1093/eurheartj/ehi058 15618043
52. Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE). I Skoog H Lithell L Hansson D Elmfeldt A Hofman B Olofsson P Trenkwalder A Zanchetti, Am J Hypertens 2005 18 1052 1059 10.1016/j.amjhyper. 2005.02.013 16109319
53. T-type and L-type calcium channel blockers exert opposite effects on renin secretion and renin gene expression in conscious rats. C Wagner BK Kramer M Hinder M Kieninger A Kurtz, Br J Pharmacol 1998 124 579 585 10.1038/sj.bjp.0701861 9647484
54. Renin release by diuretics. L Nascimento JM Ayala RA Baquero M Martinez-Maldonado, J Pharmacol Exp Ther 1979 208 522 526 430369
55. Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial. M Di Bari M Pahor LV Franse RI Shorr JY Wan L Ferrucci GW Somes WB Applegate, Am J Epidemiol 2001 153 72 78 10.1093/aje/153.1.72 11159149
56. Inhibition of angiotensin-converting enzyme modulates the autoregulation of regional cerebral blood flow in hypertensive rats. S Sadoshima T Nagao S Ibayashi M Fujishima, Hypertension 1994 23 781 785 8206577
57. Captopril improves cerebrovascular structure and function in old hypertensive rats. F Dupuis J Atkinson P Liminana JM Chillon, Br J Pharmacol 2005 144 349 356 10.1038/sj.bjp.0706001 15655534
58. Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Y Nishimura T Ito JM Saavedra, Stroke 2000 31 2478 2486 11022082
59. Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist. T Ito H Yamakawa C Bregonzio JA Terron A Falcon-Neri JM Saavedra, Stroke 2002 33 2297 2303 10.1161/01.STR.0000027274.03779.F3 12215602
60. Normalization of endothelial and inducible nitric oxide synthase expression in brain microvessels of spontaneously hypertensive rats by angiotensin II AT1 receptor inhibition. H Yamakawa M Jezova H Ando JM Saavedra, J Cereb Blood Flow Metab 2003 23 371 380 10.1097/00004647-200303000-00012 12621312
61. Blockade of angiotensin II provides additional benefits in hypertension- and ageing-related cardiac and vascular dysfunctions beyond its blood pressure-lowering effects. B Demirci PP McKeown U Bayraktutan, J Hypertens 2005 23 2219 2227 10.1097/01.hjh.0000191906.03983.ee 16269964
62. Long-term angiotensin-converting enzyme inhibitor perindopril therapy improves cerebral perfusion reserve in patients with previous minor stroke. J Hatazawa E Shimosegawa Y Osaki M Ibaraki N Oku S Hasegawa K Nagata Y Hirata Y Miura, Stroke 2004 35 2117 2122 10.1161/01.STR.0000136034.86144.e9 15256675
63. Antihypertensive therapy increases cerebral blood flow and carotid distensibility in hypertensive elderly subjects. LA Lipsitz M Gagnon M Vyas I Iloputaife DK Kiely F Sorond J Serrador DM Cheng V Babikian LA Cupples, Hypertension 2005 45 216 221 10.1161/01.HYP.0000153094.09615.11 15655124
64. Losartan, an angiotensin II (AT1) receptor antagonist, preserves cerebral blood flow in hypertensive patients with a history of stroke. H Moriwaki H Uno Y Nagakane K Hayashida K Miyashita H Naritomi, J Hum Hypertens 2004 18 693 699 10.1038/sj.jhh.1001735 15129230
65. Diabetic brain damage in hypertension: role of renin-angiotensin system. K Kario J Ishikawa S Hoshide Y Matsui M Morinari K Eguchi S Ishikawa K Shimada, Hypertension 2005 45 887 893 10.1161/01.HYP.0000163460.07639.3f 15824198
66. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function. S Morimoto K Maki Y Aota T Sakuma T Iwasaka, Hypertens Res 2008 31 1603 1610 10.1291/hypres.31.1603 18971536
67. Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function. EL Schiffrin JB Park Q Pu, J Hypertens 2002 20 71 78 10.1097/00004872-200201000-00011 11791028
68. AT(2) but not AT(1) receptor antagonism abolishes angiotensin II increase of the acquisition of conditioned avoidance responses in rats. JJ Braszko, Behav Brain Res 2002 131 79 86 10.1016/S0166-4328(01)00349-7 11844574
69. Neuroprotection with angiotensin receptor antagonists: a review of the evidence and potential mechanisms. H Wilms P Rosenstiel T Unger G Deuschl R Lucius, Am J Cardiovasc Drugs 2005 5 245 253 10.2165/00129784-200505040-00004 15984907
70. The pleiotropic effects of Angiotensin receptor blockers. SG Chrysant GS Chrysant, J Clin Hypertens (Greenwich) 2006 8 261 268 10.1111/j.1524-6175.2005. 05264.x 16596029
71. A one-year study of the antiatherosclerotic effect of the angiotensin-II receptor blocker losartan in hypertensive patients. A comparison with angiotension-converting enzyme inhibitors. M Sonoda T Aoyagi K Takenaka K Uno R Nagai, Int Heart J 2008 49 95 103 10.1536/ihj.49.95 18360068
72. CLOX: an executive clock drawing task. DR Royall JA Cordes M Polk, J Neurol Neurosurg Psychiatry 1998 64 588 594 10.1136/jnnp.64.5.588 9598672
73. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. C Randolph MC Tierney E Mohr TN Chase, J Clin Exp Neuropsychol 1998 20 310 319 10.1076/jcen.20.3.310.823 9845158
74. Age- and education-corrected independent normative data for the RBANS in a community dwelling elderly sample. K Duff D Patton MR Schoenberg J Mold JG Scott RL Adams, Clin Neuropsychol 2003 17 351 366 14704885
75. Angiotensinogen Met235Thr polymorphism, angiotensin-converting enzyme inhibitor therapy, and the risk of nonfatal stroke or myocardial infarction in hypertensive patients. JC Bis NL Smith BM Psaty SR Heckbert KL Edwards RN Lemaitre T Lumley FR Rosendaal, Am J Hypertens 2003 16 1011 1017 10.1016/j.amjhyper.2003.07.018 14643574
76. Physical Activity Scale for the Elderly (PASE): the relationship with activity measured by a portable accelerometer. RA Washburn JL Ficker, J Sports Med Phys Fitness 1999 39 336 340 10726435
77. Assessment of older people: self-maintaining and instrumental activities of daily living. MP Lawton EM Brody, Gerontologist 1969 9 179 186 5349366
78. Recommendations for blood pressure measurement in humans and experimental animals. Part 2: Blood pressure measurement in experimental animals: a statement for professionals from the subcommittee of professional and public education of the American Heart Association council on high blood pressure research. TW Kurtz KA Griffin AK Bidani RL Davisson JE Hall, Hypertension 2005 45 299 310 10.1161/01.HYP.0000150857.39919.cb 15611363
79. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. TG Pickering JE Hall LJ Appel BE Falkner J Graves MN Hill DW Jones T Kurtz SG Sheps EJ Roccella, Hypertension 2005 45 142 161 15611362 (Pubitemid 40066429)
80. Population-based norms for the Mini-Mental State Examination by age and educational level. RM Crum JC Anthony SS Bassett MF Folstein, Jama 1993 269 2386 2391 10.1001/jama.269.18.2386 8479064
81. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. MF Folstein SE Folstein PR McHugh, J Psychiatr Res 1975 12 189 198 10.1016/0022-3956(75)90026-6 1202204
82. Construct and concurrent validity of the Hopkins Verbal Learning Test-revised. AM Shapiro RH Benedict D Schretlen J Brandt, Clin Neuropsychol 1999 13 348 358 10726605
83. Memory and motor skill components of the WAIS-III Digit Symbol-Coding subtest. DS Kreiner JJ Ryan, Clin Neuropsychol 2001 15 109 113 11778571
84. D Wechsler, WMS-R: Wechsler Memory Scale - Revised: manual San Antonio: Psychological Corp: Harcourt Brace Jovanovich 1987
85. Dynamic regulation of middle cerebral artery blood flow velocity in aging and hypertension. LA Lipsitz S Mukai J Hamner M Gagnon V Babikian, Stroke 2000 31 1897 1903 10926954
86. Transcranial Doppler: clinical and experimental uses. DW Newell R Aaslid, Cerebrovasc Brain Metab Rev 1992 4 122 143 1627439
87. Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. R Aaslid TM Markwalder H Nornes, J Neurosurg 1982 57 769 774 10.3171/jns.1982.57.6.0769 7143059
88. Dynamic Regulation of Middle Cerebral Artery Blood Flow Velocity in Aging and Hypertension. LA Lipsitz S Mukai J Hamner M Gagnon V Babikian, Stroke 2000 31 1897 1903 10926954
89. Aldosterone and renin measurements. S Cartledge N Lawson, Ann Clin Biochem 2000 37 Pt 3 262 278 10.1258/0004563001899401 10817239
90. The simultaneous measurement of aldosterone, cortisol, and corticosterone in human peripheral plasma by displacement analysis. RH Underwood GH Williams, J Lab Clin Med 1972 79 848 862 5062996
91. Double antibody radioimmunoassay of renin activity and angiotensin II in human peripheral plasma. RL Emanuel JP Cain GH Williams, J Lab Clin Med 1973 81 632 640 4348744
92. Angiotensin-Converting Enzyme Inhibitor-Induced Cough: ACCP Evidence-Based Clinical Practice Guidelines. PV Dicpinigaitis, Chest 2006 129 169S 173 10.1378/chest.129.1-suppl.169S 16428706
93. Incidence and Characteristics of Angioedema Associated With Enalapril. JB Kostis HJ Kim J Rusnak T Casale A Kaplan J Corren E Levy, Arch Intern Med 2005 165 1637 1642 10.1001/archinte.165.14.1637 16043683
94. P Diggle K Liang S Zeger, Analysis of Longitudinal Data Oxford University Press 1994
95. P McCullagh J Nelder, Generalized Liner Models London.: Chapman and Hall 1987
96. Low systolic blood pressure is associated with impaired cognitive function in the oldest old: longitudinal observations in a population-based sample 80 years and older. SE Nilsson S Read S Berg B Johansson A Melander U Lindblad, Aging Clin Exp Res 2007 19 41 47 17332720
97. The association between low diastolic blood pressure in middle age and cognitive function in old age. A population-based study. L Kilander H Nyman M Boberg H Lithell, Age Ageing 2000 29 243 248 10.1093/ageing/29.3.243 10855907
98. Low ambulatory blood pressure is associated with lower cognitive function in healthy elderly men. J Axelsson F Reinprecht A Siennicki-Lantz S Elmstahl, Blood Press Monit 2008 13 269 275 10.1097/MBP.0b013e32830d4be6 18799952